Synthesis and structure–activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of Dorsomorphin: The discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe

Autor: Engers, Darren W., Frist, Audrey Y., Lindsley, Craig W., Hong, Charles C., Hopkins, Corey R.
Zdroj: In Bioorganic & Medicinal Chemistry Letters 1 June 2013 23(11):3248-3252
Databáze: ScienceDirect